Brief: ADAR1 Capital Management - ISS Recommends Withholding Votes From Keros Therapeutics Directors Mary Ann Gray & Alpna Seth At Annual Meeting
21/05/2025 13:50
May 21 (Reuters) - Keros Therapeutics Inc KROS.O: ADAR1 CAPITAL MANAGEMENT - ISS RECOMMENDS WITHHOLDING VOTES FROM KEROS THERAPEUTICS DIRECTORS MARY ANN GRAY & ALPNA SETH AT ANNUAL MEETING Source text: ID:nPndnHgBa Further company coverage: KROS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops